Inovio Pharmaceuticals
INO
INO
123 hedge funds and large institutions have $156M invested in Inovio Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 114 → 123 (+9)
0.19% less ownership
Funds ownership: 3.4% → 3.21% (-0.19%)
Holders
123
Holding in Top 10
–
Calls
$6.12M
Puts
$3.98M
Top Buyers
| 1 | +$2.64M | |
| 2 | +$2.36M | |
| 3 | +$2.35M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$2.17M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.6M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$3.08M | |
| 3 | -$1.65M | |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$1.19M |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$1.06M |